Coronavirus: Covaxin will probably be not less than 60% efficient, says Bharat Biotech
Biotechnology firm Bharat Biotech mentioned on Sunday that Covaxin, its coronavirus vaccine candidate, will probably be not less than 60%…
Read MoreTag: Bharat Biotech
_1594052644844_1594052732451_1605952560806.jpg){kind=small}
Bharat Biotech didn’t report Covaxin part 1 trial hostile occasion in August
NEW DELHI: Bharat Biotech Worldwide Ltd had an hostile occasion in the course of the part 1 trial in August,…
Read More